Home›Compare›MadeMed vs Raeliva

MadeMed vs Raeliva: Which Is Better?

Head-to-head comparison of MadeMed and Raeliva based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Raeliva scores higher overall in our independent evaluation (61.2/100 vs 57.3/100), leading on trust & safety, value, experience. MadeMed comes out ahead on product range. MadeMed has the lower entry price (from $30/mo vs $117/mo), so the better value depends on which treatment you need.

57

MadeMed is a Houston-registered telehealth brand selling compounded injectable and oral GLP-1s, sermorelin, NAD+ and tadalafil through the Xpedicare provider network.

Visit MadeMed
61

Raeliva is a 2026-launched GLP-1 and longevity storefront built on the CareValidate platform, with flat dose-independent pricing and prepay discounts.

Visit Raeliva

Score Breakdown

DimensionMadeMedRaeliva
Overall Score57.3/10061.2/100 ✓
Trust & Safety30%55/10060/100 ✓
Value25%66/10072/100 ✓
Experience20%45/10062/100 ✓
Product Range15%72/100 ✓55/100
Reputation10%45/10045/100

At a Glance

Founded—2026
HeadquartersHouston, TXSan Diego, CA
Publicly tradedNoNo
Treatment categories32
Treatments listed77
Starting price$30/mo$117/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMadeMedRaeliva
Weight Loss / GLP-1$99–$199
Compounded Semaglutide (injectable)
$150–$219
Compounded Semaglutide Injections
Longevity & Peptides$129–$229
Sermorelin (injectable or oral)
$117–$179
NAD+

MadeMed

+Offers both injectable and oral/sublingual versions of semaglutide, tirzepatide and sermorelin, plus NAD+ as injection or nasal spray
+Operating entity, provider network (Xpedicare) and a partner pharmacy (Red Rock) are named in the terms and About page
+Advertised GLP-1 entry pricing from $99/mo is at the low end of the market
−Product pages showed no pricing or product detail during our research, in a direct fetch or a real browser
−Advertised prices and state coverage (about 40 states) come from brand-issued press releases and can't be verified on-site
−No Trustpilot or other independent patient reviews; public coverage is mostly paid newswire content
Read the full MadeMed review →

Raeliva

+Clear operator disclosure: names the platform operator, the billing/intake vendor (CareValidate), the medical group (Lion MDs, with physician NPIs) and six dispensing pharmacies
+Flat pricing at every dose for semaglutide and tirzepatide, published on each product page
+Accepts transfers at the patient's current GLP-1 dose after provider review, with no charge if not eligible
−Launched in 2026 with ~1,500 claimed patients and only 12 Trustpilot reviews, all five-star and posted within two months
−Lowest advertised rates require 6- or 12-month prepayment ($900–1,450 upfront), and dispensed medication is non-refundable
−Runs on CareValidate's white-label telehealth stack, so the clinical and billing experience is shared with other storefronts
Read the full Raeliva review →

MadeMed vs Raeliva — FAQ

Is MadeMed better than Raeliva?

▾

Raeliva scores higher overall in our independent evaluation (61.2/100 vs 57.3/100), leading on trust & safety, value, experience. MadeMed comes out ahead on product range. MadeMed has the lower entry price (from $30/mo vs $117/mo), so the better value depends on which treatment you need.

Is MadeMed or Raeliva cheaper?

▾

MadeMed has the lower starting price (from $30/mo vs $117/mo for Raeliva). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MadeMed and Raeliva both offer?

▾

Both platforms treat Weight Loss / GLP-1, Longevity & Peptides. MadeMed covers 3 treatment categories total and Raeliva covers 2.

Still deciding?